It was known that TSC1 or TSC2 gene mutations in TSC patients may cause the neurodegeneration and the development of benign tumors, such as liver or renal angiomyolipomas, renal cell carcinomas, and hamartomas et al. [11–13]. Here, TSC1 is linked to hereditary clear cell renal cell carcinoma.